PET Imaging CCR2 in Lung Inflammation

Status Recruiting

Clinical Trial Summary

The primary objective of this study is to assess the lung distribution of the Positron Emission Tomography (PET) imaging radiotracer Cu-DOTA-ECL1i, which binds to the specific population inflammatory cells, in patients with fibrotic lung diseases. This objective includes sub-studies to assess radiotracer distribution in the lung, the reproducibility of PET scans and the relationship of the scan to distribution of inflammatory cells in human lung tissue. The overall goal is to assess the potential of the radiotracer to track inflammatory cells in lung diseases.

Clinical Trial Description

This is a single site, pilot Phase 0/1 clinical trial to establish the uptake of Cu-DOTA-ECL1i in additional patients with ILD fibrotic lung disease (n=60). Healthy volunteers without known pulmonary disease will be recruited as controls (N=5). All subjects will be recruited and undergo one dynamic PET/CT scan to characterize the lung uptake of Cu-DOTA-ECL1i. Among those with pulmonary fibrosis imaging, an arterial catheter will be placed for blood draws in n=10 subjects, an additional sub group of subjects (n=10) will undergo a second PET/CT within two months. A third subgroup of subjects (n=10) who undergo lung transplant will have analysis of CCR2+ cells in their explanted lungs. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03492762
Study type	Interventional
Source	Washington University School of Medicine
Contact	Steven Brody, MD
Phone	314-362-8969
Email	brodys@wustl.edu
Status	Recruiting
Phase	Early Phase 1
Start date	February 27, 2018
Completion date	August 31, 2025

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT03309358` - A Study of the Safety and Tolerability of Inhaled SNSP113 in Healthy Subjects and Subjects With Stable Cystic Fibrosis	Phase 1
Recruiting	`NCT04115514` - Treatment of ARDS With Instilled T3	Phase 2
Completed	`NCT02277002` - Commuter Air Pollution Intervention Study	N/A
Completed	`NCT05260827` - The Effects of Heated Tobacco Products Use on Lung Function and Volatile Organic Compounds in Exhaled Air	N/A
Completed	`NCT04606069` - Treat COVID-19 Patients With Regadenoson	Phase 1/Phase 2
Completed	`NCT02151552` - Assessing NOS Uptake With PET Imaging in Lung Inflammation	Early Phase 1
Recruiting	`NCT05854563` - Cough Capture as a Portal Into the Lung
Active, not recruiting	`NCT05752019` - TAAI Erasmus Research Initiative to Fight CF: Monitoring Inflammation in CF Lung Disease Into a New Era
Completed	`NCT00741013` - Quantifying Airway Inflammation With Radiologic Tests	Phase 0
Completed	`NCT01174056` - Evaluation of Rosiglitazone Anti-inflammatory Effect With FDG-PET Imaging	Phase 0
Completed	`NCT02743468` - Cytochrome P450 Epoxygenase Pathway Regulation of Macrophage Function
Recruiting	`NCT04755478` - LUS to Assess Lung Injury After Lung Lobectomy
Completed	`NCT03905837` - Impact of Lidocaine Administration on Postoperative Complications During Lung Resection Surgery	Phase 4
Recruiting	`NCT03312712` - Validation of the Analysis Methodology Behind the Use of Quantitative 18F-FDG PET/CT to Assess Lung Inflammation
Recruiting	`NCT04677309` - LUS to Assess Lung Injury After Lung Resection
Terminated	`NCT02848586` - Effects of E-cigarettes (ECIGs) on Pulmonary Inflammation and Behavior in HIV Infected Smokers	N/A
Enrolling by invitation	`NCT04781153` - Bergen Oral Respiratory Intervention Study	N/A
Withdrawn	`NCT04782700` - P-Co-Li (Pulmonary Covid-19 Study)	N/A